Related references
Note: Only part of the references are listed.Maintenance avelumab versus continuation of first-line chemotherapy in gastric cancer: JAVELIN Gastric 100 study design
Markus Moehler et al.
FUTURE ONCOLOGY (2019)
Chemotherapy versus chemoradiotherapy after surgery and preoperative chemotherapy for resectable gastric cancer (CRITICS): an international, open-label, randomised phase 3 trial
Annemieke Cats et al.
LANCET ONCOLOGY (2018)
Phase III, randomised trial of avelumab versus physician's choice of chemotherapy as third-line treatment of patients with advanced gastric or gastro-oesophageal junction cancer: primary analysis of JAVELIN Gastric 300
Y. -J. Bang et al.
ANNALS OF ONCOLOGY (2018)
Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries
Freddie Bray et al.
CA-A CANCER JOURNAL FOR CLINICIANS (2018)
CheckMate-032 Study: Efficacy and Safety of Nivolumab and Nivolumab Plus Ipilimumab in Patients With Metastatic Esophagogastric Cancer
Yelena Y. Janjigian et al.
JOURNAL OF CLINICAL ONCOLOGY (2018)
CYTO-CHIP: Cytoreductive surgery versus cytoreductive surgery and hyperthermic intraperitoneal chemotherapy for gastric cancer with peritoneal metastasis: A propensity-score analysis from BIG RENAPE and FREGAT working groups.
Pierre Emmanuel Bonnot et al.
JOURNAL OF CLINICAL ONCOLOGY (2018)
Molecular Characterization of Gastric Carcinoma: Therapeutic Implications for Biomarkers and Targets
Lionel Kankeu Fonkoua et al.
BIOMEDICINES (2018)
The 30-year experienced-A meta-analysis of randomised and high-quality non-randomised studies of hyperthermic intraperitoneal chemotherapy in the treatment of gastric cancer
Jacopo Desiderio et al.
EUROPEAN JOURNAL OF CANCER (2017)
Nivolumab in patients with advanced gastric or gastro-oesophageal junction cancer refractory to, or intolerant of, at least two previous chemotherapy regimens (ONO-4538-12, ATTRACTION-2): a randomised, double-blind, placebo-controlled, phase 3 trial
Yoon-Koo Kang et al.
LANCET (2017)
Chemotherapy for advanced gastric cancer
Anna Dorothea Wagner et al.
COCHRANE DATABASE OF SYSTEMATIC REVIEWS (2017)
Efficacy of Sequential Ipilimumab Monotherapy versus Best Supportive Care for Unresectable Locally Advanced/Metastatic Gastric or Gastroesophageal Junction Cancer
Yung-Jue Bang et al.
CLINICAL CANCER RESEARCH (2017)
TOPGEAR: A Randomized, Phase III Trial of Perioperative ECF Chemotherapy with or Without Preoperative Chemoradiation for Resectable Gastric Cancer: Interim Results from an International, Intergroup Trial of the AGITG, TROG, EORTC and CCTG
Trevor Leong et al.
ANNALS OF SURGICAL ONCOLOGY (2017)
Perioperative chemotherapy with docetaxel, oxaliplatin, and fluorouracil/leucovorin (FLOT) versus epirubicin, cisplatin, and fluorouracil or capecitabine (ECF/ECX) for resectable gastric or gastroesophageal junction (GEJ) adenocarcinoma (FLOT4-AIO): A multicenter, randomized phase 3 trial.
Salah-Eddin Al-Batran et al.
JOURNAL OF CLINICAL ONCOLOGY (2017)
The IGCA staging system is more accurate than AJCC7 system in stratifying survival of patients with gastric cancer in stage III
Ping Shu et al.
BMC CANCER (2017)
ESOPEC: prospective randomized controlled multicenter phase III trial comparing perioperative chemotherapy (FLOT protocol) to neoadjuvant chemoradiation (CROSS protocol) in patients with adenocarcinoma of the esophagus (NCT02509286)
Jens Hoeppner et al.
BMC CANCER (2016)
Pembrolizumab for patients with PD-L1-positive advanced gastric cancer (KEYNOTE-012): a multicentre, open-label, phase 1b trial
Kei Muro et al.
LANCET ONCOLOGY (2016)
Multicenter phase III trial of adjuvant chemoradiotherapy in stomach tumors 2 (ARTIST 2)
Se Hoon Park et al.
JOURNAL OF CLINICAL ONCOLOGY (2015)
Molecular analysis of gastric cancer identifies subtypes associated with distinct clinical outcomes
Razvan Cristescu et al.
NATURE MEDICINE (2015)
Randomized phase II trial of nimotuzumab plus irinotecan versus irinotecan alone as second-line therapy for patients with advanced gastric cancer
Taroh Satoh et al.
GASTRIC CANCER (2015)
Diagnostic accuracy of endoscopic ultrasonography (EUS) for the preoperative locoregional staging of primary gastric cancer
Simone Mocellin et al.
COCHRANE DATABASE OF SYSTEMATIC REVIEWS (2015)
Extent of lymph node dissection for adenocarcinoma of the stomach
Simone Mocellin et al.
COCHRANE DATABASE OF SYSTEMATIC REVIEWS (2015)
The Relevance of the Siewert Classification in the Era of Multimodal Therapy for Adenocarcinoma of the Gastro-Oesophageal Junction
Nathan J. Curtis et al.
JOURNAL OF SURGICAL ONCOLOGY (2014)
The Critical Role of Peritoneal Cytology in the Staging of Gastric Cancer: An Evidence-Based Review
James P. De Andrade et al.
JOURNAL OF SURGICAL ONCOLOGY (2014)
Ramucirumab monotherapy for previously treated advanced gastric or gastro-oesophageal junction adenocarcinoma (REGARD): an international, randomised, multicentre, placebo-controlled, phase 3 trial
Charles S. Fuchs et al.
LANCET (2014)
Ramucirumab plus paclitaxel versus placebo plus paclitaxel in patients with previously treated advanced gastric or gastro-oesophageal junction adenocarcinoma (RAINBOW): a double-blind, randomised phase 3 trial
Hansjochen Wilke et al.
LANCET ONCOLOGY (2014)
Comprehensive molecular characterization of gastric adenocarcinoma
Adam J. Bass et al.
NATURE (2014)
Endoscopic submucosal dissection vs endoscopic mucosal resection for early gastric cancer: A meta-analysis
Antonio Facciorusso et al.
WORLD JOURNAL OF GASTROINTESTINAL ENDOSCOPY (2014)
A systematic review of the accuracy and indications for diagnostic laparoscopy prior to curative-intent resection of gastric cancer
Pierre-Anthony Leake et al.
GASTRIC CANCER (2012)
A meta-analysis of endoscopic submucosal dissection and EMR for early gastric cancer
Jingjing Lian et al.
GASTROINTESTINAL ENDOSCOPY (2012)
Phase III Trial Comparing Capecitabine Plus Cisplatin Versus Capecitabine Plus Cisplatin With Concurrent Capecitabine Radiotherapy in Completely Resected Gastric Cancer With D2 Lymph Node Dissection: The ARTIST Trial
Jeeyun Lee et al.
JOURNAL OF CLINICAL ONCOLOGY (2012)
Updated Analysis of SWOG-Directed Intergroup Study 0116: A Phase III Trial of Adjuvant Radiochemotherapy Versus Observation After Curative Gastric Cancer Resection
Stephen R. Smalley et al.
JOURNAL OF CLINICAL ONCOLOGY (2012)
Preoperative Chemoradiotherapy for Esophageal or Junctional Cancer
P. van Hagen et al.
NEW ENGLAND JOURNAL OF MEDICINE (2012)
Treatment of Gastric Cancer With Peritoneal Carcinomatosis by Cytoreductive Surgery and HIPEC: A Systematic Review of Survival, Mortality, and Morbidity
Richdeep S. Gill et al.
JOURNAL OF SURGICAL ONCOLOGY (2011)
Peritoneal Carcinomatosis from Gastric Cancer: A Multi-Institutional Study of 159 Patients Treated by Cytoreductive Surgery Combined with Perioperative Intraperitoneal Chemotherapy
Olivier Glehen et al.
ANNALS OF SURGICAL ONCOLOGY (2010)
Trastuzumab in combination with chemotherapy versus chemotherapy alone for treatment of HER2-positive advanced gastric or gastro-oesophageal junction cancer (ToGA): a phase 3, open-label, randomised controlled trial
Yung-Jue Bang et al.
LANCET (2010)
Surgical treatment of gastric cancer: 15-year follow-up results of the randomised nationwide Dutch D1D2 trial
Ilfet Songun et al.
LANCET ONCOLOGY (2010)
HER2 in gastric cancer: a new prognostic factor and a novel therapeutic target
C. Gravalos et al.
ANNALS OF ONCOLOGY (2008)
Staging accuracy of esophageal cancer by endoscopic ultrasound: A meta-analysis and systematic review
Srinivas R. Puli et al.
WORLD JOURNAL OF GASTROENTEROLOGY (2008)
Clinical impact of lymphadenectomy extent in resectable gastric cancer of advanced stage
Roderich E. Schwarz et al.
ANNALS OF SURGICAL ONCOLOGY (2007)
Perioperative chemotherapy versus surgery alone for resectable gastroesophageal cancer
David Cunningham et al.
NEW ENGLAND JOURNAL OF MEDICINE (2006)
Staging and follow-up of gastrointestinal tumors with PET/CT
SJ Rosenbaum et al.
ABDOMINAL IMAGING (2006)
Endoscopic mucosal resection for early cancers of the upper gastrointestinal tract
R Soetikno et al.
JOURNAL OF CLINICAL ONCOLOGY (2005)
Laparoscopic versus open subtotal gastrectomy for distal gastric cancer - Five-year results of a randomized prospective trial
CGS Huscher et al.
ANNALS OF SURGERY (2005)
Cytoreductive surgery with intraperitoneal hyperthermic chemotherapy for advanced gastric cancer
JY Hall et al.
JOURNAL OF GASTROINTESTINAL SURGERY (2004)
Robot-assisted gastric surgery
M Hashizume et al.
SURGICAL CLINICS OF NORTH AMERICA (2003)
Share Paper
